{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380017287054750722.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Frank Rigo"}],"foaf:familyName":[{"@value":"Rigo"}],"foaf:givenName":[{"@value":"Frank"}]}],"career":[{"institution":{"notation":[{"@value":"Ionis Pharmaceuticals, Carlsbad, CA 92010, USA."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360017287054750720","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1126/scitranslmed.abe1923"},{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1126/scitranslmed.abe1923"},{"@type":"URI","@value":"https://www.science.org/doi/pdf/10.1126/scitranslmed.abe1923"}],"notation":[{"@value":"Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1126/scitranslmed.abe1923_Dke21OTdiiAMpGWGzlDMvggHBDG"}]}